Sino Biopharmaceut Stock Price, News & Analysis (OTCMKTS:SBMFF)

$1.58 -0.06 (-3.66 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$1.58
Today's Range$1.58 - $1.58
52-Week Range$0.72 - $1.47
Volume8,000 shs
Average Volume16,745 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Sino Biopharmaceut (OTCMKTS:SBMFF)

Sino Biopharmaceut logoSino Biopharmaceutical Limited, researches, develops, manufactures, and markets Chinese medicines and chemical medicines in Hong Kong. The company operates through three segments: Modernized Chinese Medicines and Chemical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections, Runzhong dispersible tablets, Mingzheng capsules, Tianqingganping enteric capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Yilunping and Tuotuo tablets, as well as Tianqingning injections; and oncology medicines consisting of Zhiruo, Saiweijian, and Tianqingyitai injections. The company’s principal products also include Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Getai tablets. In addition, it develops medicines for treating tumors, analgesia, diabetes, and other diseases; engages in the retail of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development services; and operates Chia Tai Shaoyang Orthopedic Hospital. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:SBMFF
CUSIPN/A
Phone852-2802-9886

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio31.56
P/E Growth2.91

Sales & Book Value

Annual Sales$2.04 billion
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees18,163
Outstanding SharesN/A

Sino Biopharmaceut (OTCMKTS:SBMFF) Frequently Asked Questions

What is Sino Biopharmaceut's stock symbol?

Sino Biopharmaceut trades on the OTCMKTS under the ticker symbol "SBMFF."

Who are some of Sino Biopharmaceut's key competitors?

How do I buy Sino Biopharmaceut stock?

Shares of Sino Biopharmaceut can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sino Biopharmaceut's stock price today?

One share of Sino Biopharmaceut stock can currently be purchased for approximately $1.58.

How can I contact Sino Biopharmaceut?

Sino Biopharmaceut's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]


MarketBeat Community Rating for Sino Biopharmaceut (SBMFF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  28
MarketBeat's community ratings are surveys of what our community members think about Sino Biopharmaceut and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sino Biopharmaceut (OTCMKTS:SBMFF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: SellSellSellSell
Consensus Rating Score: 1.001.001.001.00
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Sino Biopharmaceut (OTCMKTS:SBMFF) Consensus Price Target History

Price Target History for Sino Biopharmaceut (OTCMKTS:SBMFF)

Sino Biopharmaceut (OTCMKTS:SBMFF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/18/2017Jefferies GroupInitiated CoverageUnderperformView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Earnings History for Sino Biopharmaceut (OTCMKTS:SBMFF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Sino Biopharmaceut (OTCMKTS:SBMFF) Earnings Estimates

Current Year EPS Consensus Estimate: $0.05 EPS
Next Year EPS Consensus Estimate: $0.06 EPS

Dividends

Dividend History for Sino Biopharmaceut (OTCMKTS:SBMFF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sino Biopharmaceut (OTCMKTS SBMFF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Sino Biopharmaceut (OTCMKTS SBMFF) News Headlines

Source:
DateHeadline
Research Analysts Offer Predictions for Sino Biopharmaceuts FY2017 Earnings (SBMFF)Research Analysts Offer Predictions for Sino Biopharmaceut's FY2017 Earnings (SBMFF)
www.americanbankingnews.com - December 13 at 8:08 AM
Sino Biopharmaceutical Ltd. : Fairly valued, but may deserve another lookSino Biopharmaceutical Ltd. : Fairly valued, but may deserve another look
finance.yahoo.com - December 1 at 4:14 PM

SEC Filings

Sino Biopharmaceut (OTCMKTS:SBMFF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Sino Biopharmaceut (OTCMKTS SBMFF) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.